Skip to main content
. 2020 Nov 10;10:19471. doi: 10.1038/s41598-020-76570-9

Figure 2.

Figure 2

De novo assigned gut microbiota enterotypes among 46 participants receiving outpatient addiction treatment, 2016–2017. The prevalence of three enterotypes identified through Dirichlet multinomial mixture modeling differed by opioid agonist–antagonist exposure groups. No individuals who used opioid agonists (agonist only [Ag] nor agonist–antagonist combination [AgAt]) had the Prevotella enterotype and 4 of 5 Ag participants had a Bacteroides enterotype with elevated Clostridium cluster XIVa. The distribution of enterotypes differed between Ag participants vs. participants who used neither agonists nor antagonists (N, Fisher exact p value = 0.006). Ag agonist only, AgAt agonist–antagonist, At antagonist only, N neither agonist nor antagonist.